ImmuVen
Champaign
About ImmuVen
ImmuVenis is a biotechnology company with novel technology to discover and develop new biotherapeutics to treat infectious disease, cancer and autoimmune disorders
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.9M
- Funding stage: M&A
- Last round: Grant (May 2012)
- Website: immuven.com
- Phone: 2172391948
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Canonical: https://fsome.com/organization/immuven-1711325 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.